Cargando…

Antithrombotic therapy for secondary prevention of unprovoked venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials

BACKGROUND: Extended antithrombotic treatment is recommended for secondary prevention of unprovoked venous thromboembolism (VTE), however, there is no consensus on which antithrombotic strategy is preferable. AIM: To compare the efficacy and safety of different antithrombotic strategies for secondar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Dandan, Liu, Yi, Song, Yao, Wen, Aiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759723/ https://www.ncbi.nlm.nih.gov/pubmed/35023788 http://dx.doi.org/10.1080/07853890.2022.2026002

Ejemplares similares

Extended anticoagulation for unprovoked venous thromboembolism
por: Castellucci, Lana A., et al.
Publicado: (2018)

Screening for cancer in unprovoked venous thromboembolism
por: Shivji, Salma, et al.
Publicado: (2019)

Sulodexide for Secondary Prevention of Recurrent Venous Thromboembolism: A Systematic Review and Meta-Analysis
por: Jiang, Qing-Jun, et al.
Publicado: (2018)

Should lifelong anticoagulation for unprovoked venous thromboembolism be revisited?
por: Moodley, Otto, et al.
Publicado: (2015)

Exploring Opportunities for Primary Prevention of Unprovoked Venous Thromboembolism: Ready for Prime Time?
por: Folsom, Aaron R., et al.
Publicado: (2020)

Genetic Risk Profiling Associated with Recurrent Unprovoked Venous Thromboembolism
por: Hodeib, Hossam, et al.
Publicado: (2021)

Management of Patients With Unprovoked Venous Thromboembolism: An Evidence-Based and Practical Approach
por: Marcucci, Maura, et al.
Publicado: (2013)

Validation of a prognostic score for hidden cancer in unprovoked venous thromboembolism
por: Jara-Palomares, Luis, et al.
Publicado: (2018)

Clinical outcomes of prolonged anticoagulation with rivaroxaban after unprovoked venous thromboembolism
por: Berger, Jeffrey S., et al.
Publicado: (2017)

Case Report: Unprovoked venous thromboembolism in a young adult male
por: Dhabhar, Jeyhan, et al.
Publicado: (2019)

Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD‐VTE
por: Ageno, Walter, et al.
Publicado: (2021)

Outcomes in infants with unprovoked venous thromboembolism: A retrospective cohort study
por: Whitworth, Hilary, et al.
Publicado: (2023)

The prevalence and clinical manifestation of hereditary thrombophilia in Korean patients with unprovoked venous thromboembolisms
por: Lee, Su Yeon, et al.
Publicado: (2017)

Long‐Term Effects of Unprovoked Venous Thromboembolism on Mortality and Major Cardiovascular Events
por: Chang, Wei‐Ting, et al.
Publicado: (2017)

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis
por: Khan, Faizan, et al.
Publicado: (2019)

Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis
por: van Es, Nick, et al.
Publicado: (2017)

Impact of D-Dimer for Prediction of Incident Occult Cancer in Patients with Unprovoked Venous Thromboembolism
por: Han, Donghee, et al.
Publicado: (2016)

Rivaroxaban Treatment for Patients With Unprovoked or Provoked Venous Thromboembolism　― Subanalysis of the J’xactly Study ―
por: Hisatake, Shinji, et al.
Publicado: (2022)

Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism
por: Wells, Philip S., et al.
Publicado: (2022)

Antithrombotic therapy for venous thromboembolism in myeloproliferative neoplasms
por: De Stefano, Valerio, et al.
Publicado: (2018)

Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE
por: Ensor, Joie, et al.
Publicado: (2016)

Correction: Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis
Publicado: (2017)

Acute myocardial infarction after initially diagnosed with unprovoked venous thromboembolism: A case report
por: Seo, Jeongduk, et al.
Publicado: (2023)

Risk scores for occult cancer in patients with unprovoked venous thromboembolism: Results from an individual patient data meta‐analysis
por: Mulder, Frits I., et al.
Publicado: (2020)

New Oral Anticoagulants for Venous Thromboembolism Prophylaxis in Total Hip and Knee Arthroplasty: A Systematic Review and Network Meta-Analysis
por: Yi, Yi-hu, et al.
Publicado: (2022)

Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis
por: Hohaus, Stefan, et al.
Publicado: (2020)

D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study
por: Palareti, Gualtiero, et al.
Publicado: (2022)

CT imaging for occult malignancy in patients with unprovoked venous thromboembolism (VTE) in a tertiary centre: is it worthwhile?
por: Lee, Ronan J., et al.
Publicado: (2023)

Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis
por: Khan, Faizan, et al.
Publicado: (2017)

Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol
por: Khan, Faizan, et al.
Publicado: (2019)

Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis
por: Mai, Vicky, et al.
Publicado: (2019)

Reduced proliferation of endothelial colony-forming cells in unprovoked venous thromboembolic disease as a consequence of endothelial dysfunction
por: Hernandez-Lopez, Rubicel, et al.
Publicado: (2017)

Predictive Value for Increased Red Blood Cell Distribution Width in Unprovoked Acute Venous Thromboembolism at the Emergency Department
por: Febra, Cláudia, et al.
Publicado: (2023)

Protocol for a systematic review of prognostic models for the recurrence of venous thromboembolism (VTE) following treatment for a first unprovoked VTE
por: Ensor, Joie, et al.
Publicado: (2013)

Outcomes beyond the Third Month of Anticoagulation in Patients Aged >75 Years with a First Episode of Unprovoked Venous Thromboembolism
por: Iñurrieta, Amaia, et al.
Publicado: (2018)

Protocol for a modelling study to assess the clinical and cost-effectiveness of indefinite anticoagulant therapy for first unprovoked venous thromboembolism
por: Khan, Faizan, et al.
Publicado: (2023)

Treatment and secondary prevention of venous thromboembolism in cancer
por: Coleman, R, et al.
Publicado: (2010)

Cancer Screening in Patients with Unprovoked Thromboembolism: How to do it and Who Benefits?
por: Ferreira, Filipa, et al.
Publicado: (2020)

Risk of venous thromboembolism with janus kinase inhibitors in inflammatory immune diseases: a systematic review and meta-analysis
por: Zhang, Juqi, et al.
Publicado: (2023)

Antithrombotic Regimens in Patients With Percutaneous Coronary Intervention Whom an Anticoagulant Is Indicated: A Systematic Review and Network Meta-Analysis
por: Bunmark, Wipharak, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qa59p2h4g3to3rv27g10l0ee7i